Havemeyer Place LP bought a new stake in Teleflex Incorporated (NYSE:TFX – Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 7,854 shares of the medical technology company’s stock, valued at approximately $959,000.
Other institutional investors also recently modified their holdings of the company. Banque Cantonale Vaudoise raised its stake in shares of Teleflex by 82.5% in the fourth quarter. Banque Cantonale Vaudoise now owns 250 shares of the medical technology company’s stock valued at $31,000 after acquiring an additional 113 shares during the last quarter. Hantz Financial Services Inc. raised its stake in shares of Teleflex by 248.8% in the third quarter. Hantz Financial Services Inc. now owns 279 shares of the medical technology company’s stock valued at $34,000 after acquiring an additional 199 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. bought a new position in shares of Teleflex in the third quarter valued at approximately $35,000. V Square Quantitative Management LLC bought a new position in Teleflex in the 4th quarter worth approximately $37,000. Finally, Sound Income Strategies LLC acquired a new position in Teleflex during the 4th quarter worth $45,000. Institutional investors own 95.62% of the company’s stock.
Wall Street Analysts Forecast Growth
Several research analysts have issued reports on the company. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Teleflex in a report on Friday, March 27th. Needham & Company LLC upped their price objective on Teleflex from $138.00 to $147.00 and gave the stock a “buy” rating in a report on Thursday, February 26th. Truist Financial reaffirmed a “hold” rating and set a $143.00 price objective (up from $135.00) on shares of Teleflex in a report on Monday, May 11th. Zacks Research raised Teleflex from a “strong sell” rating to a “hold” rating in a report on Tuesday, April 28th. Finally, Royal Bank Of Canada raised Teleflex from a “sector perform” rating to an “outperform” rating and upped their price objective for the stock from $135.00 to $155.00 in a report on Friday, May 8th. Three investment analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, Teleflex has a consensus rating of “Hold” and a consensus price target of $144.00.
Teleflex Stock Performance
Shares of Teleflex stock opened at $129.90 on Monday. The firm has a fifty day moving average of $127.08 and a two-hundred day moving average of $118.14. The stock has a market capitalization of $5.75 billion, a price-to-earnings ratio of -5.70, a PEG ratio of 0.97 and a beta of 0.82. Teleflex Incorporated has a 52 week low of $100.18 and a 52 week high of $139.67. The company has a debt-to-equity ratio of 0.82, a quick ratio of 2.03 and a current ratio of 2.55.
Teleflex (NYSE:TFX – Get Free Report) last issued its earnings results on Thursday, May 7th. The medical technology company reported $1.39 EPS for the quarter, beating the consensus estimate of $1.21 by $0.18. The company had revenue of $548.30 million during the quarter, compared to analysts’ expectations of $536.91 million. Teleflex had a negative net margin of 35.88% and a positive return on equity of 13.29%. The business’s revenue for the quarter was up 32.3% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.44 EPS. Teleflex has set its FY 2026 guidance at 6.250-6.550 EPS. As a group, equities research analysts predict that Teleflex Incorporated will post 6.7 EPS for the current year.
Teleflex Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, June 30th. Shareholders of record on Monday, May 25th will be given a dividend of $0.34 per share. The ex-dividend date is Friday, May 22nd. This represents a $1.36 annualized dividend and a dividend yield of 1.0%. Teleflex’s payout ratio is presently -5.96%.
Teleflex Company Profile
Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.
The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.
Featured Articles
- Five stocks we like better than Teleflex
- These 3 Insurance Stocks Made New 52-Week Highs: Still Time to Buy?
- 3 Stocks Under $20 to Buy Before a Broader Market Rally
- Petco Faces Tough Competition, But Momentum Is Building
- The Lock-In Effect Is Real—These 3 Homebuilders Are Betting on It
Want to see what other hedge funds are holding TFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teleflex Incorporated (NYSE:TFX – Free Report).
Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.
